An edition of Vandetanib (Schilddrüsenkarzinom) (2017)

Vandetanib (Schilddrüsenkarzinom)

Nutzenbewertung gemäß § 35a SGB V

Version 1.0
  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read
Vandetanib (Schilddrüsenkarzinom)
Institut für Qualität und Wirt ...
Not in Library

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

Buy this book

Last edited by MARC Bot
April 26, 2022 | History
An edition of Vandetanib (Schilddrüsenkarzinom) (2017)

Vandetanib (Schilddrüsenkarzinom)

Nutzenbewertung gemäß § 35a SGB V

Version 1.0
  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

This edition doesn't have a description yet. Can you add one?

Buy this book

Edition Availability
Cover of: Vandetanib (Schilddrüsenkarzinom)
Vandetanib (Schilddrüsenkarzinom): Nutzenbewertung gemäß § 35a SGB V
2017, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
in German - Version 1.0

Add another edition?

Book Details


Edition Notes

Bandzählung 506 innerhalb der Schriftenreihe doppelt vergeben. Siehe auch IDN 1134881967.

Archivierung/Langzeitarchivierung gewährleistet

Published in
Köln
Series
IQWiG-Berichte -- 506, IQWiG-Berichte -- 506

Classifications

Dewey Decimal Class
616.994

The Physical Object

Pagination
Online-Ressource

ID Numbers

Open Library
OL37839569M
OCLC/WorldCat
992999540
Deutsche National Bibliothek
1134882904

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
April 26, 2022 Created by MARC Bot import new book